Early intermittent hyperlipidaemia alters tissue macrophages to fuel atherosclerosis.

Autor: Takaoka M; Department of Medicine, Section of CardioRespiratory Medicine, University of Cambridge, Heart and Lung Research Institute, Cambridge, UK., Zhao X; Department of Medicine, Section of CardioRespiratory Medicine, University of Cambridge, Heart and Lung Research Institute, Cambridge, UK., Lim HY; Immunology Translational Research Programme, Yong Loo Lin School of Medicine, Department of Microbiology and Immunology, National University of Singapore, Singapore, Singapore.; Immunology Programme, Life Sciences Institute, National University of Singapore, Singapore, Singapore., Magnussen CG; Research Centre of Applied and Preventive Cardiovascular Medicine; University of Turku, Turku, Finland.; Centre for Population Health Research, University of Turku and Turku University Hospital, Turku, Finland.; Baker Heart and Diabetes Institute, Melbourne, Victoria, Australia., Ang O; Immunology Translational Research Programme, Yong Loo Lin School of Medicine, Department of Microbiology and Immunology, National University of Singapore, Singapore, Singapore.; Immunology Programme, Life Sciences Institute, National University of Singapore, Singapore, Singapore., Suffee N; Université Paris Cité, Institut National de la Santé et de la Recherche Médicale, U970, PARCC, Paris, France., Schrank PR; Department of Integrative Biology & Physiology, Center for Immunology, University of Minnesota, Minneapolis, MN, USA., Ong WS; Immunology Translational Research Programme, Yong Loo Lin School of Medicine, Department of Microbiology and Immunology, National University of Singapore, Singapore, Singapore.; Immunology Programme, Life Sciences Institute, National University of Singapore, Singapore, Singapore., Tsiantoulas D; Department of Medicine, Section of CardioRespiratory Medicine, University of Cambridge, Heart and Lung Research Institute, Cambridge, UK.; Department of Laboratory Medicine, Medical University of Vienna, Vienna, Austria., Sommer F; Institute of Clinical Molecular Biology, University of Kiel and University Hospital Schleswig Holstein (UKSH), Kiel, Germany., Mohanta SK; Institute for Cardiovascular Prevention, Ludwig-Maximilians-Universität München (LMU), Munich, Germany., Harrison J; Department of Medicine, Section of CardioRespiratory Medicine, University of Cambridge, Heart and Lung Research Institute, Cambridge, UK., Meng Y; Baker Heart and Diabetes Institute, Melbourne, Victoria, Australia., Laurans L; Université Paris Cité, Institut National de la Santé et de la Recherche Médicale, U970, PARCC, Paris, France., Wu F; Baker Heart and Diabetes Institute, Melbourne, Victoria, Australia., Lu Y; Department of Medicine, Section of CardioRespiratory Medicine, University of Cambridge, Heart and Lung Research Institute, Cambridge, UK., Masters L; Department of Medicine, Section of CardioRespiratory Medicine, University of Cambridge, Heart and Lung Research Institute, Cambridge, UK., Newland SA; Department of Medicine, Section of CardioRespiratory Medicine, University of Cambridge, Heart and Lung Research Institute, Cambridge, UK., Denti L; Institute of Ophthalmology, University College London, London, UK., Hong M; Institute for Cardiovascular Prevention, Ludwig-Maximilians-Universität München (LMU), Munich, Germany., Chajadine M; Université Paris Cité, Institut National de la Santé et de la Recherche Médicale, U970, PARCC, Paris, France., Juonala M; Department of Medicine, University of Turku, Turku, Finland.; Division of Medicine, Turku University Hospital, Turku, Finland., Koskinen JS; Research Centre of Applied and Preventive Cardiovascular Medicine; University of Turku, Turku, Finland.; Centre for Population Health Research, University of Turku and Turku University Hospital, Turku, Finland.; Division of Medicine, Turku University Hospital, Turku, Finland.; Department of Medicine, Satakunta Central Hospital, Pori, Finland., Kähönen M; Department of Clinical Physiology, University of Tampere, Tampere, Finland.; Faculty of Medicine and Health Technology, University of Tampere, Tampere, Finland.; Finnish Cardiovascular Research Center Tampere, University of Tampere, Tampere, Finland., Pahkala K; Research Centre of Applied and Preventive Cardiovascular Medicine; University of Turku, Turku, Finland.; Centre for Population Health Research, University of Turku and Turku University Hospital, Turku, Finland., Rovio SP; Research Centre of Applied and Preventive Cardiovascular Medicine; University of Turku, Turku, Finland.; Centre for Population Health Research, University of Turku and Turku University Hospital, Turku, Finland., Mykkänen J; Research Centre of Applied and Preventive Cardiovascular Medicine; University of Turku, Turku, Finland.; Centre for Population Health Research, University of Turku and Turku University Hospital, Turku, Finland., Thomson R; Baker Heart and Diabetes Institute, Melbourne, Victoria, Australia.; Analytical Edge, Hobart, Tasmania, Australia., Kaisho T; Department of Immunology, Institute of Advanced Medicine, Wakayama Medical University, Wakayama, Japan., Habenicht AJR; Institute for Cardiovascular Prevention, Ludwig-Maximilians-Universität München (LMU), Munich, Germany., Clement M; Department of Medicine, Section of CardioRespiratory Medicine, University of Cambridge, Heart and Lung Research Institute, Cambridge, UK., Tedgui A; Université Paris Cité, Institut National de la Santé et de la Recherche Médicale, U970, PARCC, Paris, France., Ait-Oufella H; Université Paris Cité, Institut National de la Santé et de la Recherche Médicale, U970, PARCC, Paris, France., Zhao TX; Department of Medicine, Section of CardioRespiratory Medicine, University of Cambridge, Heart and Lung Research Institute, Cambridge, UK., Nus M; Department of Medicine, Section of CardioRespiratory Medicine, University of Cambridge, Heart and Lung Research Institute, Cambridge, UK., Ruhrberg C; Institute of Ophthalmology, University College London, London, UK., Taleb S; Université Paris Cité, Institut National de la Santé et de la Recherche Médicale, U970, PARCC, Paris, France., Williams JW; Department of Integrative Biology & Physiology, Center for Immunology, University of Minnesota, Minneapolis, MN, USA., Raitakari OT; Research Centre of Applied and Preventive Cardiovascular Medicine; University of Turku, Turku, Finland.; Centre for Population Health Research, University of Turku and Turku University Hospital, Turku, Finland.; Department of Clinical Physiology and Nuclear Medicine, Turku University Hospital, Turku, Finland., Angeli V; Immunology Translational Research Programme, Yong Loo Lin School of Medicine, Department of Microbiology and Immunology, National University of Singapore, Singapore, Singapore.; Immunology Programme, Life Sciences Institute, National University of Singapore, Singapore, Singapore., Mallat Z; Department of Medicine, Section of CardioRespiratory Medicine, University of Cambridge, Heart and Lung Research Institute, Cambridge, UK. zm255@medschl.cam.ac.uk.; Université Paris Cité, Institut National de la Santé et de la Recherche Médicale, U970, PARCC, Paris, France. zm255@medschl.cam.ac.uk.

Publikováno v: Nature [Nature] 2024 Oct; Vol. 634 (8033), pp. 457-465. Date of Electronic Publication: 2024 Sep 04.

Blood Pressure at Different Life Stages Over the Early Life Course and Intima-Media Thickness.

Autor: Meng Y; Baker Heart and Diabetes Institute, Melbourne, Victoria, Australia.; Menzies Institute for Medical Research, University of Tasmania, Hobart, Tasmania, Australia.; Baker Department of Cardiometabolic Health, Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Melbourne, Victoria, Australia., Sharman JE; Menzies Institute for Medical Research, University of Tasmania, Hobart, Tasmania, Australia., Koskinen JS; Research Centre of Applied and Preventive Cardiovascular Medicine, University of Turku, Turku, Finland.; Centre for Population Health Research, University of Turku and Turku University Hospital, Turku, Finland.; Division of Medicine, Turku University Hospital, Turku, Finland.; Department of Medicine, Satakunta Central Hospital, Pori, Finland., Juonala M; Division of Medicine, Turku University Hospital, Turku, Finland.; Department of Medicine, University of Turku, Turku, Finland., Viikari JSA; Division of Medicine, Turku University Hospital, Turku, Finland.; Department of Medicine, University of Turku, Turku, Finland., Buscot MJ; Menzies Institute for Medical Research, University of Tasmania, Hobart, Tasmania, Australia., Wu F; Baker Heart and Diabetes Institute, Melbourne, Victoria, Australia.; Baker Department of Cardiometabolic Health, Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Melbourne, Victoria, Australia., Fraser BJ; Menzies Institute for Medical Research, University of Tasmania, Hobart, Tasmania, Australia.; Alliance for Research in Exercise, Nutrition and Activity (ARENA), University of South Australia, Adelaide, South Australia, Australia., Rovio SP; Research Centre of Applied and Preventive Cardiovascular Medicine, University of Turku, Turku, Finland.; Centre for Population Health Research, University of Turku and Turku University Hospital, Turku, Finland., Kähönen M; Department of Clinical Physiology, Tampere University Hospital and Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland., Rönnemaa T; Division of Medicine, Turku University Hospital, Turku, Finland.; Department of Medicine, University of Turku, Turku, Finland., Jula A; Department of Chronic Disease Prevention, Institute for Health and Welfare, Turku, Finland., Niinikoski H; Research Centre of Applied and Preventive Cardiovascular Medicine, University of Turku, Turku, Finland.; Centre for Population Health Research, University of Turku and Turku University Hospital, Turku, Finland.; Department of Pediatrics and Adolescent Medicine, Turku University Hospital, University of Turku, Turku, Finland., Raitakari OT; Research Centre of Applied and Preventive Cardiovascular Medicine, University of Turku, Turku, Finland.; Centre for Population Health Research, University of Turku and Turku University Hospital, Turku, Finland.; Department of Clinical Physiology and Nuclear Medicine, Turku University Hospital, University of Turku, Turku, Finland., Pahkala K; Research Centre of Applied and Preventive Cardiovascular Medicine, University of Turku, Turku, Finland.; Centre for Population Health Research, University of Turku and Turku University Hospital, Turku, Finland.; Paavo Nurmi Centre, Unit of Health and Physical Activity, University of Turku, Turku, Finland., Magnussen CG; Baker Heart and Diabetes Institute, Melbourne, Victoria, Australia.; Research Centre of Applied and Preventive Cardiovascular Medicine, University of Turku, Turku, Finland.; Centre for Population Health Research, University of Turku and Turku University Hospital, Turku, Finland.

Publikováno v: JAMA pediatrics [JAMA Pediatr] 2024 Feb 01; Vol. 178 (2), pp. 133-141.

Early cardiovascular structural and functional abnormalities as a guide to future morbid events.

Autor: Koskinen JS; Research Centre of Applied and Preventive Cardiovascular Medicine, University of Turku, Finland.; Centre for Population Health Research, University of Turku and Turku University Hospital, Finland.; Division of Medicine, Turku University Hospital, Finland.; Department of Medicine, Satakunta Central Hospital, Finland., Raitakari OT; Research Centre of Applied and Preventive Cardiovascular Medicine, University of Turku, Finland.; Centre for Population Health Research, University of Turku and Turku University Hospital, Finland.; Department of Clinical Physiology and Nuclear Medicine, University of Turku, Finland.

Publikováno v: European journal of preventive cardiology [Eur J Prev Cardiol] 2021 Dec 29; Vol. 28 (15), pp. e1-e2.